AIMS-Medical S.L. Obtains Funding to Boost its Technology. At AIMS-Medical we are back from holidays with good news. The spin-off…
admina27/09/2023
We had the honour of participating in the conference promoted by Unió Catalana d'Hospitals on Artificial Intelligence AI: a mosaic…
admina22/06/2023
The prevalence of oropharyngeal dysphagia in hospitalised elderly is 47%. Among them, 98.7% have nutritional risk, 75.3% dehydration and 32.3%…
admina22/06/2023
AIMS-Medical Spin-off will be present at the World Dysphagia Summit and 31st DRS conference, San Francisco (USA) 2023 to present…
admina01/03/2023
In January 2023 the Spin-off AIMS-Medical received the invention patent grant from the Spanish Patent and Trademark Office.
admina01/01/2023
Oropharyngeal dysphagia is underdiagnosed and current screening is costly. We aimed: (a) to develop an expert system (ES) based on…
admina28/12/2022
AIMS-OD provides systematic, real-time OD screening, enabling the selection of the most appropriate diagnostic and therapeutic strategies for each patient.
admina12/12/2022
At the ASENEM Congress 2022, we highlighted the under-diagnosis of oropharyngeal dysphagia in COVID19 patients (4.6% codified vs. 25.5% detected…
admina05/11/2022
AIMS-Medical won the Creatic award for the best business initiative in the field of technology and innovation.
admina11/11/2021
